Literature DB >> 12625659

Use of unconventional therapies by individuals with multiple sclerosis.

Sangeetha Nayak1, Robert J Matheis, Nancy E Schoenberger, Samuel C Shiflett.   

Abstract

OBJECTIVE: To examine the prevalence and patterns of use of complementary and alternative medicine (CAM) among individuals with multiple sclerosis (MS) in the USA and to explore the reasons for use, symptoms treated and perceived effectiveness of these therapies.
METHODS: Surveys were mailed to the entire mailing list of the MS Foundation, constituting 11,600 individuals with MS or their family members; 3,140 adults with MS returned surveys, yielding a response rate of 27.1%.
RESULTS: More than half of the responding sample (57.1%) had used at least one CAM modality. The longer that people had MS and the less satisfied they were with conventional health care the more likely they were to use CAM therapies. The most common reasons for using CAMs were the desire to use holistic health care (i.e., treatments that recognized the interrelatedness of mind, body and spirit) and dissatisfaction with conventional medicine. Ingested herbs were the most frequently used CAM modalities (26.6%), followed by chiropractic manipulation (25.5%), massage (23.3%) and acupuncture (19.9%). Women were 25% more likely than men and whites were 30% more likely than non-whites to use CAM therapies. There was no significant relationship between the frequency of use and the reported efficacy of the CAM techniques (r = 0.17, p > 0.10).
CONCLUSIONS: The prevalence of CAM use in this population warrants more research on the efficacy and safety of these therapies, especially those with high usage or high efficacy ratings, such as herbs, chiropractic manipulation and massage, but for which there is little or no research evidence for efficacy or safety.

Entities:  

Mesh:

Year:  2003        PMID: 12625659     DOI: 10.1191/0269215503cr604oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  46 in total

Review 1.  Complementary and alternative medicine: is there a role in multiple sclerosis?

Authors:  Vijayshree Yadav; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

Review 3.  Therapeutic Yoga: Symptom Management for Multiple Sclerosis.

Authors:  Kim A Rogers; Megan MacDonald
Journal:  J Altern Complement Med       Date:  2015-08-13       Impact factor: 2.579

4.  Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Authors:  Annett Apel; Brigitte Greim; Nicolaus König; Uwe K Zettl
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

Review 5.  Complementary and alternative medicine and coping in neuroimmunological diseases.

Authors:  A Apel; B Greim; U K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 6.  Great expectations: what do patients using complementary and alternative medicine hope for?

Authors:  E Ernst; S K Hung
Journal:  Patient       Date:  2011       Impact factor: 3.883

Review 7.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

8.  Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis.

Authors:  Nuray Dayapoğlu; Mehtap Tan
Journal:  J Altern Complement Med       Date:  2012-09-11       Impact factor: 2.579

9.  Relaxation and health-related quality of life in multiple sclerosis: the example of autogenic training.

Authors:  Georgina Sutherland; Mark B Andersen; Tony Morris
Journal:  J Behav Med       Date:  2005-06

10.  A randomized pilot study of naturopathic medicine in multiple sclerosis.

Authors:  Lynne Shinto; Carlo Calabrese; Cynthia Morris; Vijayshree Yadav; Debbie Griffith; Rachel Frank; Barry S Oken; Sara Baldauf-Wagner; Dennis Bourdette
Journal:  J Altern Complement Med       Date:  2008-06       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.